Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Exploring the Mechanisms of Venetoclax Resistance Via Drug Screening and Genome-Wide CRISPR Screening

Adriana Ladungova, Helena Peschelova, Lenka Dostalova, Yusuf Lodhi, Narendra Varma Gottumukkala, Jiri Mayer, Michal Smida

Blood (2023) 142 (Supplement 1): 5759.

https://doi.org/10.1182/blood-2023-189245

Published: 2023

Journal Articles

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

Klaudyna Fidyt, Marta Krawczyk, Monika Pepek, Katsiaryna Marhelava, Agnieszka Kraft, Malgorzata Bobrowicz, Aleksandra Kusowska, Joanna Barankiewicz, Przemyslaw Juszczynski, Michal Smida, Myron Czuczman, Francisco Hernandez-Ilizaliturri, Malgorzata Firczuk, Magdalena Winiarska

Blood (2022) 140 (Supplement 1): 10273–10274.

https://doi.org/10.1182/blood-2022-162292

Published: 2022

Journal Articles

Epigenetic Drug Screen on Resistant CLL Cells Reveals Aurora Kinase Inhibitors As Enhancers of CD20 Expression and Sensitizers to Treatment with CD20 Monoclonal Antibodies

Veronika Kozlova, Aneta Ledererova, Michael Doubek, MD PhD, Jiri Mayer, MD, Sarka Pospisilova, Michal Smida, PhD MSc

Blood (2018) 132 (Supplement 1): 4407.

https://doi.org/10.1182/blood-2018-99-118669

Published: 2018

Journal Articles

Cellular Mechanisms Regulating CD20 As a Target of Monoclonal Antibody Therapy in B-Lymphoid Malignancies

Michal Smida, Veronika Kozlova, Viera Vakulova, Aneta Ledererova, Michael Doubek, Jiri Mayer, Sarka Pospisilova

Blood (2016) 128 (22): 3968.

https://doi.org/10.1182/blood.V128.22.3968.3968

Published: 2016

Journal Articles

A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation

Michal Smida, Anita Posevitz-Fejfar, Vaclav Horejsi, Burkhart Schraven, Jonathan A. Lindquist

Blood (2007) 110 (2): 596–625.

https://doi.org/10.1182/blood-2006-07-038752

Published: 2007

Includes: Supplemental data

NARROW

Exploring the Mechanisms of Venetoclax Resistance Via Drug Screening and Genome-Wide CRISPR Screening

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

Epigenetic Drug Screen on Resistant CLL Cells Reveals Aurora Kinase Inhibitors As Enhancers of CD20 Expression and Sensitizers to Treatment with CD20 Monoclonal Antibodies

Cellular Mechanisms Regulating CD20 As a Target of Monoclonal Antibody Therapy in B-Lymphoid Malignancies

A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation

Email alerts

ASH Publications

American Society of Hematology

Exploring the Mechanisms of Venetoclax Resistance Via Drug Screening and Genome-Wide CRISPR Screening

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

Epigenetic Drug Screen on Resistant CLL Cells Reveals Aurora Kinase Inhibitors As Enhancers of CD20 Expression and Sensitizers to Treatment with CD20 Monoclonal Antibodies

Cellular Mechanisms Regulating CD20 As a Target of Monoclonal Antibody Therapy in B-Lymphoid Malignancies

A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only